NASDAQ:BDSX | Free Cash Flow | BIODESIX INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$10.17M$81,000.00-$10.25M
2025-12-31$778,000.00$86,000.00$692,000.00
2025-03-31-$8.6M$74,000.00-$8.68M
2024-12-31-$4.1M$839,000.00-$4.94M
2024-03-31-$15.31M$234,000.00-$15.55M
2023-12-31-$12.28M$2.98M-$15.27M
2023-03-31-$7.69M$7.68M-$15.36M
2022-12-31-$11.95M$1.93M-$13.88M
2022-03-31-$13.1M$262,000.00-$13.36M
2021-12-31-$10.2M$530,000.00-$10.73M
2021-03-31-$11.33M$466,000.00-$11.79M
2020-12-31-$8.76M$462,000.00-$9.22M
2020-03-31-$4.54M$98,000.00-$4.64M
2019-12-31-$5.73M$395,000.00-$6.12M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$23.27M$259,000.00-$23.53M
2024-12-31-$48.65M$3.23M-$51.88M
2023-12-31-$22.87M$22.92M-$45.79M
2022-12-31-$44.97M$3.3M-$48.27M
2021-12-31-$28.22M$2.24M-$30.46M
2020-12-31-$21.37M$1.95M-$23.31M
2019-12-31-$21.73M$1.31M-$23.04M